Kainos Medicine, Inc.

Kainos Medicine, Inc., is a global new company
that specializes in research and development of innovative medicines
for brain diseases, cancers, and infectious disease.

Kainos Medicine is led by researchers who have years of experience and success cases in new
drug discovery & development and an executive team who have experience in NASDAQ-listed companies.
We receive specialized counsel on project selection, evaluation, and external licensing deals from advisory
boards and business development consultants who have skills and flourishing experience in global drug development.

Kainos Medicine was established in June 2007 and is currently located at Pangyo Techno Valley.
Our company is specialized in discovery of novel drug candidates,
and in conducting preclinical and early clinical studies.
Our business model is to create profit by developing new drug
discovery projects and by transferring resulting technology to leading pharmaceutical
companies in Korea as well as overseas at the preclinical and/or early clinical stages.

In order to do so, we are utilizing our platform technology to expeditiously and
efficiently carry forward with global drug development.
Also to minimize the risks and to maximize the possibility of success for commercialization,
our company is partnering with global pharmaceutical companies
through joint research from the early development stages.